Open access
Sep 2026
In vivo and FACS-based CRISPR/Cas9 screening uncovers VENTX as a crucial element in maintaining seminoma stemness.
In conclusion, VENTX is a key regulator of seminoma stemness, presenting a promising target for therapy to address recurrence and resistance in seminoma.
Chao-Xiong Huang, Yi-Ran Chen, En-Huan Zhang et al.
· Translational Oncology · 0 citations